MEK Inhibitors 2025: A New Era in Targeted Cancer Therapy Cancer therapy has come a long way—from the days of one-size-fits-all chemotherapy to today's precision medicine. In 2025, one class of drugs is gaining fresh attention for its game-changing potential: MEK inhibitors. These targeted treatments are rewriting the script for patients with certain types of cancer, and their...